Complementation Assay |
Somatostatin receptors 1, 4 and 5 |
[21,36] |
Calcium sensing receptor |
[41] |
Muscarinic M2 and M3 receptors |
[42] |
Muscarinic M3/α2 Adrenoceptor |
[22] |
Dopamine receptor 2/3 |
[43] |
GABAR1/GABAR2
|
[44] |
Co-Immunoprecipitation |
α,β-Adrenoceptors |
[45,46] |
Dopamine receptors |
[47,48] |
Opioid receptors |
[49,50] |
Chemokine receptor 2 |
[51] |
Somatostatin receptors |
[31,32,34,35,36,52] |
Somatostatin receptor 2/µ-Opioid receptor |
[53] |
β-Adrenoceptors/Somatostatin receptor 5 |
[37,40] |
Somatostatin receptor 2A/3 |
[52] |
Angiotensin receptor 1/Cannabinoid receptor1 |
[54] |
β2 Adrenoceptor/Opioid receptor |
[55] |
GABAR1/GABAR2
|
[56,57] |
Calcium sensing receptor/Glutamate Receptors |
[58] |
FRET |
α-Adrenoceptors |
[45] |
Thyrotropin receptor |
[59] |
Neuropeptide Y receptor |
[60] |
Dopamine receptor 2 |
[61] |
Chemokine receptor 2 and 5 |
[62] |
Somatostatin Receptors |
[63,64] |
Photobleaching-FRET |
Somatostatin receptors |
[21,31,32,34,36,38] |
Gonadotrophin-releasing hormone receptors |
[65,66] |
Somatostatin receptors/Dopamine receptor |
[30,35] |
Somatostatin receptor 5/β-Adrenoceptors |
[37,40] |
Somatostatin receptor 4/µ-Opioid receptor |
[67] |
Somatostatin receptor 4/δ-Opioid receptor |
[39] |
Somatostatin receptors/EGFRs |
[15,16,17] |
BRET |
β-Adrenoceptors |
[68] |
Thyrotropin-releasing hormone receptor |
[69] |
Opioid receptors |
[70] |
Chemokine receptor 4 and 5 |
[71] |
Adenosine receptor |
[72,73] |
Oxytocin Receptor |
[10] |
Vasopressin Receptor |
[10] |
Adenosine 2a receptor/Dopamine receptor 2 |
[73] |
Adenosine 2a receptor/Purinergic receptor 2 |
[72] |
Oxytocin/Vasopressin receptors |
[10] |
Angiotensin receptor 1/Cannabinoid receptor 1 |
[54] |
TR-FRET |
δ-Opioid receptor |
[74] |
β2 Adrenoceptor/δ Opioid receptors |
[74] |
Histamine 4 receptor |
[75] |
GABAR1/GABAR2
|
[76] |